Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2017-05-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1703556114PMID 28533404PMCID PMC5468635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges

  2018cited by this paper
• Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy

  2017cited by this paper
• Influenza A Virus Infection Damages Zebrafish Skeletal Muscle and Exacerbates Disease in Zebrafish Modeling Duchenne Muscular Dystrophy

  2017cited by this paper
• Conditional Loss of Pten in Myogenic Progenitors Leads to Postnatal Skeletal Muscle Hypertrophy But Age‐dependent Exhaustion of Satellite Cells

  2016cited by this paper
• A normal life without muscle dystrophin.

  2015cited by this paper
• Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy

  2015cited by this paper
• Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study

  2015cited by this paper
• Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.

  2015influential reference
• Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants

  2014cited by this paper
• Zebrafish based small molecule screens for novel DMD drugs.

  2013cited by this paper
• LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy

  2013cited by this paper
• Zebrafish based small molecule screens for novel DMD drugs.

  2013cited by this paper
• An optimized microRNA backbone for effective single-copy RNAi.

  2013cited by this paper
• Zebrafish housing systems: a review of basic operating principles and considerations for design and functionality.

  2012cited by this paper
• Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration

  2012cited by this paper
• Isolation and characterization of human fetal myoblasts.

  2012cited by this paper
• Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.

  2011cited by this paper
• Regulation of DMD pathology by an ankyrin-encoded miRNA

  2011cited by this paper
• The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

  2011cited by this paper
• Phosphatidylinositol transfer proteins: negotiating the regulatory interface between lipid metabolism and lipid signaling in diverse cellular processes.

  2011cited by this paper
• Zebrafish MTMR14 is required for excitation-contraction coupling, developmental motor function and the regulation of autophagy.

  2010cited by this paper
• Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.

  2010cited by this paper
• Zebrafish models of collagen VI-related myopathies

  2010cited by this paper
• PTEN Inhibition Improves Muscle Regeneration in Mice Fed a High-Fat Diet

  2010cited by this paper
• SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

  2010cited by this paper
• Zebrafish Class 1 Phosphatidylinositol Transfer Proteins: PITPβ and Double Cone Cell Outer Segment Integrity in Retina

  2010cited by this paper
• Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta.

  2009cited by this paper
• Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy.

  2009cited by this paper
• PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle.

  2009cited by this paper
• Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation

  2009cited by this paper
• Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.

  2008cited by this paper
• Myogenic Akt signaling upregulates the utrophin–glycoprotein complex and promotes sarcolemma stability in muscular dystrophy

  2008cited by this paper
• Regulation of PI3K signalling by the phosphatidylinositol transfer protein PITPα during axonal extension in hippocampal neurons

  2008influential reference
• The Diverse Biological Functions of Phosphatidylinositol Transfer Proteins in Eukaryotes

  2006cited by this paper
• Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway.

  2006cited by this paper
• Insulin-like Growth Factor-1 (IGF-1) Inversely Regulates Atrophy-induced Genes via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Pathway*

  2005cited by this paper
• Evidence for a protein transported through the secretory pathway en route to the higher plant chloroplast

  2005cited by this paper
• Phosphatidylinositol transfer protein-α in netrin-1-induced PLC signalling and neurite outgrowth

  2005cited by this paper
• Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy

  2004cited by this paper
• IDENTIFICATION OF A ZEBRAFISH MODEL OF MUSCULAR DYSTROPHY

  2004cited by this paper
• Mice Lacking Phosphatidylinositol Transfer Protein-α Exhibit Spinocerebellar Degeneration, Intestinal and Hepatic Steatosis, and Hypoglycemia*

  2003cited by this paper
• Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo

  2003cited by this paper
• Genetic ablation of phosphatidylinositol transfer protein function in murine embryonic stem cells.

  2002cited by this paper
• Myogenic Akt Signaling Regulates Blood Vessel Recruitment during Myofiber Growth

  2002cited by this paper
• Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle

  2002cited by this paper
• In silico prediction of protein-protein interactions in human macrophages

  2001cited by this paper
• Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways

  2001cited by this paper
• Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele.

  1999cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Duchenne muscular dystrophy

  1995cited by this paper
• Muscular dystrophy in a litter of golden retriever dogs

  1988cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper
• Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene

  1986cited by this paper

• Cigarette Smoke Extract Combined with LPS Upregulates PITPβ Expression in Chronic Pulmonary Inflammation and May Be Related to the EGFR/ERK Signaling Pathway.

  2026cites this paper
• Muscle-specific increased expression of JAG1 improves the skeletal muscle phenotype in dystrophin-deficient mice.

  2025cites this paper
• ACTN3 genotype influences androgen response in developing murine skeletal muscle

  2025cites this paper
• Zebrafish: Lessons and Insights into Skeletal Muscle Research.

  2025cites this paper
• A brief history of phosphatidylinositol transfer proteins: from the backwaters of cell biology to prime time in lipid signaling.

  2025cites this paper
• Label-free Detection of Urine Extracellular Vesicles from Duchenne Muscular Dystrophy Patients Using Surface-Enhanced Raman Spectroscopy Combined with Machine Learning Models

  2025cites this paper
• Muscle-specific increased expression of JAG1 improves skeletal muscle phenotype in dystrophin-deficient mice

  2025cites this paper
• Exploring the Effects of Metformin on the Body via the Urine Proteome

  2025cites this paper
• Mammalian START-like phosphatidylinositol transfer proteins - Physiological perspectives and roles in cancer biology.

  2024cites this paper
• Transplantation-based screen identifies inducers of muscle progenitor cell engraftment across vertebrate species

  2023cites this paper
• Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β

  2023cites this paper
• Is the fundamental pathology in Duchenne's muscular dystrophy caused by a failure of glycogenolysis–glycolysis in costameres?

  2023cites this paper
• Establishment of mouse line showing inducible priapism‐like phenotypes

  2022cites this paper
• GWAS on Imputed Whole-Genome Sequence Variants Reveal Genes Associated with Resistance to Piscirickettsia salmonis in Rainbow Trout (Oncorhynchus mykiss)

  2022cites this paper
• Tandem duplication within the DMD gene in Labrador retrievers with a mild clinical phenotype

  2022cites this paper
• Sistemas Integrados de Gestión: un análisis bibliométrico

  2022cites this paper
• β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy

  2021cites this paper
• Transcriptome-wide study revealed m6A regulation of embryonic muscle development in Dingan goose (Anser cygnoides orientalis)

  2021cites this paper
• Courier service for phosphatidylinositol: PITPs deliver on demand

  2021cites this paper
• X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterization.

  2020cites this paper
• Perturbation of PI3K/Akt signaling affected autophagy modulation in dystrophin-deficient myoblasts

  2020cites this paper
• Therapeutic Targeting of PTEN in Duchenne Muscular Dystrophy.

  2020cites this paper
• PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA

  2020cites this paper
• Lipid transfer proteins and instructive regulation of lipid kinase activities: Implications for inositol lipid signaling and disease.

  2020cites this paper
• PTEN Inhibition Ameliorates Muscle Degeneration and Improves Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy

  2020influential citation
• X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation

  2020cites this paper
• “DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies”

  2020cites this paper
• A zebrafish model of nondystrophic myotonia with sodium channelopathy.

  2020cites this paper
• Design of Muscle Gene Therapy Expression Cassette

  2019cites this paper
• The Dog Model in the Spotlight: Legacy of a Trustful Cooperation

  2019cites this paper
• Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients

  2019cites this paper
• Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy

  2018cites this paper
• Advances in the Understanding of Skeletal Myopathies from Zebrafish Models

  2018cites this paper
• Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges

  2018cites this paper
• The interface between phosphatidylinositol transfer protein function and phosphoinositide signaling in higher eukaryotes

  2018cites this paper
• Recent advances and new insights into muscular lymphangiogenesis in health and disease

  2018cites this paper
• Influenza A Virus Infection Damages Zebrafish Skeletal Muscle and Exacerbates Disease in Zebrafish Modeling Duchenne Muscular Dystrophy

  2017cites this paper